找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Innovations for Next-Generation Antibody-Drug Conjugates; Marc Damelin Book 2018 Springer International Publishing AG, part of Springer Na

[復(fù)制鏈接]
樓主: 和善
31#
發(fā)表于 2025-3-27 00:06:09 | 只看該作者
32#
發(fā)表于 2025-3-27 04:11:00 | 只看該作者
Combining ADCs with Immuno-Oncology Agents,nogenic cell death (ICD), which leads to potent stimulation of effector T-cell activation as well as their recruitment into tumors. It has been recently demonstrated that some ADC payloads are also able to elicit ICD. Furthermore, several cytotoxic warheads used in ADCs can directly induce dendritic
33#
發(fā)表于 2025-3-27 09:16:23 | 只看該作者
Utility of PK-PD Modeling and Simulation to Improve Decision Making for Antibody-Drug Conjugate Devssful application of this tool can not only enhance the scientific understanding of the processes underlying PK-PD of ADCs but can also provide comprehensive model-derived outcomes that can help accelerate the decision-making process. Within this book chapter, we have discussed an array of different
34#
發(fā)表于 2025-3-27 11:01:43 | 只看該作者
HER2-Targeted ADCs: At the Forefront of ADC Technology Development,different drug linkers, drug to antibody ratios, site-specific antibody drug conjugates, and biparatopic antibody drug conjugates. Anti-HER2 antibody drug conjugates currently in clinical testing are described. Promising early clinical data are emerging from some of the ADCs employing novel technolo
35#
發(fā)表于 2025-3-27 16:54:00 | 只看該作者
36#
發(fā)表于 2025-3-27 21:33:33 | 只看該作者
Next Horizons: ADCs Beyond Oncology, account for designing ADCs for non-oncology indications, including payload and antibody selection. With the evolution of ADC platform and technology, more ADCs for non-oncology indications are yet to be developed.
37#
發(fā)表于 2025-3-28 01:25:40 | 只看該作者
and biomechanics as well as the pathophysiologyleading to various cervical degenerative disorders and the possible neurological sequelae. ?Subsequent chapters outline characteristics of the clinical presentation and the various diagnostic modalities to evaluate these patients. ?Key elements involved
38#
發(fā)表于 2025-3-28 04:38:31 | 只看該作者
39#
發(fā)表于 2025-3-28 09:12:51 | 只看該作者
Frank Comer,Changshou Gao,Steve Coatsspace and promoted a localized IA effect. Subretinal IA dissolved in BSS caused less severe and less consistent PR degeneration. Healon? or BSS alone did not induce PR damage. Thus, a model with PR-lacking area centralis has been created by subretinal injection of IA with a viscous solution. This mo
40#
發(fā)表于 2025-3-28 12:25:37 | 只看該作者
Jack Lin,Jason Sagerts of novel polymers with inherent environmentally favorable properties such as renewability and degradability and a series of interesting monomers found in the metabolisms and cycles of nature are given.978-3-642-07597-1978-3-540-45734-3Series ISSN 0065-3195 Series E-ISSN 1436-5030
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-6 20:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
谢通门县| 绥阳县| 保山市| 诸城市| 镇雄县| 太仆寺旗| 广河县| 邵武市| 和林格尔县| 中江县| 巴彦淖尔市| 广元市| 台中市| 山东| 蓝田县| 芒康县| 霍邱县| 岳阳县| 张掖市| 信宜市| 祥云县| 吴川市| 卫辉市| 吉木萨尔县| 深水埗区| 乌鲁木齐县| 离岛区| 滕州市| 东兴市| 和硕县| 宜川县| 原平市| 丰县| 浦北县| 道孚县| 汉阴县| 额济纳旗| 浠水县| 蓝田县| 璧山县| 榕江县|